Simpler Test May Be Best for Diagnosing Blood Cl... (least every two hours during a flight an...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Simpler Test May Be Best for Diagnosing Blood Clots in Leg

Date:10/7/2008

least every two hours during a flight, and to do calf exercises -- like you're stepping on a gas pedal -- periodically during your flight.

More information

To learn more about deep vein thrombosis, visit the U.S. National Heart, Lung, and Blood Institute.

SOURCES: Enrico Bernardi, M.D., Ph.D., head, emergency department, Conegliano Hospital, Italy; C. Seth Landefeld, M.D., professor of medicine, and chief, division of geriatrics, University of California, San Francisco; Mark Adelman, M.D., chief, division of vascular and endovascular surgery, New York University Langone Medical Center, New York City; Oct. 8, 2008, Journal of the American Medical Association

Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
2. LA BioMed research finds simpler way to assess breast cancer risk
3. Simpler Anemia Treatment May Help Kidney Patients
4. Safer, Simpler, Better & Cost Effective Cosmetic Surgery Anesthesia
5. GP targets on heart disease should be simpler and based more on treatment and prevention
6. Study shows emergency physicians have good first instincts in diagnosing heart attacks
7. New Heart Ultrasound Research Shows Hope for Diagnosing and Treating Fatal Heart Conditions
8. New insights in diagnosing diabetes may help the millions who are undiagnosed
9. High-Tech Imaging No Better for Diagnosing Head/Neck Cancers
10. Ultrasound first, not CT, for diagnosing suspected acute appendicitis
11. Detecting, Diagnosing Breast Cancers

Post Your Comments:

Breaking Medicine News(10 mins):Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 2 Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 3 Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 4 Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 5 Health News:You Never Get a Second Chance to Make a First Impression: High-Definition for the Web 2 Health News:Dr. 90210 Rhinoplasty Specialist Now Accommodates Both the East and West Coast 2 Health News:World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins 2 Health News:World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins 3 Health News:Perkins: Senate Would Rather Mandate Abortion Funding Than Enact 'Health Care Reform' 2

[0] The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility"[0] You Never Get a Second Chance to Make a First Impression: High-Definition for the Web [0] Dr. 90210 Rhinoplasty Specialist Now Accommodates Both the East and West Coast [0] World-Renowned Vascular Surgeon to Conduct Training at Harvard Medical School Site on Non-Invasive Treatment of Veins [1] Perkins: Senate Would Rather Mandate Abortion Funding Than Enact 'Health Care Reform'

Other Medicine News:Health News:Choice Hotels Selects PAI as Qualified Vendor to Offer Health Benefits to Part-Time, Hourly Workers in Its Franchisee Base 2 Health News:Choice Hotels Selects PAI as Qualified Vendor to Offer Health Benefits to Part-Time, Hourly Workers in Its Franchisee Base 3 Health News:Boston Scientific Completes Enrollment in Landmark Heart Failure Trial 2 Health News:Boston Scientific Completes Enrollment in Landmark Heart Failure Trial 3 Health News:'Size Does Matter ... and So Does Shape ... When It Comes to Teeth,' Says Cosmetic Dentist, Dr. Denise Fundora 2 Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 2 Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 3 Health News:The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety 4 Health News:Stored Ovarian Tissue Needs Testing Before Re-Implantation 2 Health News:Life Brokerage Partners Strengthens Premium Finance Programs 2

Choice Hotels Selects PAI as Qualified Vendor to Offer Health Benefits to Part-Time, Hourly Workers in Its Franchisee Base Boston Scientific Completes Enrollment in Landmark Heart Failure Trial 'Size Does Matter ... and So Does Shape ... When It Comes to Teeth,' Says Cosmetic Dentist, Dr. Denise Fundora The Leapfrog Group Releases 2008 Hospital Survey Offering Consumers Greater Assurance of Safety Stored Ovarian Tissue Needs Testing Before Re-Implantation Life Brokerage Partners Strengthens Premium Finance Programs

Breaking Medicine Technology:Pharmacy Technician Employment Increasing Up to 32% By 2016 2 Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2 Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3 Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4 Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5 Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6 Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2 Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3 Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4 Binge Drinking Not Just a Rite of the Young 62247 1 Binge Drinking Not Just a Rite of the Young 62247 2 Healing from the Inside Out 3A Compelling New Book Explores the Intricate Connection between Body Soul and Better Health 62245 1 Healing from the Inside Out 3A Compelling New Book Explores the Intricate Connection between Body Soul and Better Health 62245 2 Baxa to Sponsor ASHP Midday Symposium 3A Creating a Culture of Safety in Pharmacy A Panel Discussion on Lessons Learned 62243 1 Baxa to Sponsor ASHP Midday Symposium 3A Creating a Culture of Safety in Pharmacy A Panel Discussion on Lessons Learned 62243 2 Baxa to Sponsor ASHP Midday Symposium 3A Creating a Culture of Safety in Pharmacy A Panel Discussion on Lessons Learned 62243 3

[0] Pharmacy Technician Employment Increasing Up to 32% By 2016 [0] Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia [0] Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia

Other Medicine Technology:Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 2 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 3 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 4 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 5 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 6 Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 7 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 2 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 3 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 4 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 5 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 6 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 7 Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 8

Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults

Medicine Products:

SURGIWIPtrade; Suture Ligature with POLYSORBtrade;SURGITIEtrade; Ligating Loop with Plain Gut Suture ENDO STITCHtrade; Triple-Stitch ENDO STITCHtrade; Single-Stitch SOFSILKtrade;